Literature DB >> 20970438

Investigation of the cardiomyocyte dysfunction in bradykinin type 2 receptor knockout mice.

Danilo Roman-Campos1, Hugo Leonardo Duarte, Enéas Ricardo Gomes, Carlos Henrique Castro, Silvia Guatimosim, Antonio José Natali, Alvair Pinto Almeida, João Bosco Pesquero, Jorge Luiz Pesquero, Jader Santos Cruz.   

Abstract

AIMS: Bradykinin type 2 receptor (B(2)R) is the key component to trigger the intracellular signaling pathway in response to bradykinin under physiological conditions. The present study sought to investigate whether the B(2)R gene deletion will have an impact on myocardial function. MAIN
METHODS: Isolated cell shortening, patch-clamp technique, Western blot and confocal microscopy. KEY
FINDINGS: Isolated cell shortening measurements showed significant reduction in B(2)R knockout (B(2)R(-/-)) left ventricular cardiac myocytes' shortening. Whole-cell recordings were used to study the electrophysiological aspects of the left ventricular B(2)R(-/-) cardiomyocytes. Results showed: 1) action potential lengthening; 2) unchanged inwardly rectifying K(+) current; 3) reduced transient outward K(+) (I(to)) and L-type Ca(2+) current densities; 5) changes in kinetic properties related to I(to) and I(Ca,L). In addition, transient sarcoplasmic reticulum (SR) Ca(2+) release was found to be smaller in B(2)R(-/-) cardiomyocytes. Importantly, evidence is provided that NO constitutive production is, at least in part, responsible for the reported electrophysiological modifications observed in cardiomyocytes from B(2)R(-/-) mice. Surprisingly, NO is not involved in the SR Ca(2+) release reduction as demonstrated in the present study. SIGNIFICANCE: Taken together, our findings indicate that B(2)R plays a fundamental role in the regulation of cardiac function and Ca(2+) homeostasis, probably through a NO dependent pathway. These results may contribute to our understanding of the kinins participation in the control of cardiac function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970438     DOI: 10.1016/j.lfs.2010.10.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Altered Cardiomyocyte Function and Trypanosoma cruzi Persistence in Chagas Disease.

Authors:  Jader Santos Cruz; Artur Santos-Miranda; Policarpo Ademar Sales-Junior; Renata Monti-Rocha; Paula Peixoto Campos; Fabiana Simão Machado; Danilo Roman-Campos
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

2.  Cardiomyocyte dysfunction during the chronic phase of Chagas disease.

Authors:  Danilo Roman-Campos; Policarpo Sales-Júnior; Hugo Leonardo Duarte; Eneas Ricardo Gomes; Silvia Guatimosim; Catherine Ropert; Ricardo Tostes Gazzinelli; Jader Santos Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

3.  Endostatin inhibits bradykinin-induced cardiac contraction.

Authors:  Jumpei Yasuda; Lila Takada; Yuka Kajiwara; Muneyosi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2015-06-05       Impact factor: 1.267

4.  Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway.

Authors:  Shi-Rong Lin; Qing-Ming Lin; Yu-Jia Lin; Xin Qian; Xiao-Ping Wang; Zheng Gong; Feng Chen; Bin Song
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

5.  Balance between the two kinin receptors in the progression of experimental focal and segmental glomerulosclerosis in mice.

Authors:  Rafael Luiz Pereira; Raphael José Ferreira Felizardo; Marcos Antônio Cenedeze; Meire Ioshie Hiyane; Enio José Bassi; Mariane Tami Amano; Clarice Sylvia Taemi Origassa; Reinaldo Correia Silva; Cristhiane Fávero Aguiar; Sylvia Mendes Carneiro; João Bosco Pesquero; Ronaldo Carvalho Araújo; Alexandre de Castro Keller; Renato C Monteiro; Ivan Cruz Moura; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Dis Model Mech       Date:  2014-04-17       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.